Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R41AT011494 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | NIH |
Not provided
Not provided
Not provided
The overall purpose of this study is to objectively describe and test the consistency and reproducibility of instrument-assisted soft tissue manipulation (IASTM).The specific aims of this current study are to:
This is a single-site study consisting of three study phases. Phase I will observe and analyze clinician's application of instrument-assisted soft tissue manipulation (IASTM) as a means to identify signature profiles for the stroke rate, angle, and direction that are characteristic of basic (e.g., linear, curved) stroke patterns. Phase II will assess the consistency of IASTM force application. Phase III will assess the reliability of dynamic pressure pain threshold assessment. Clinician participants (Phase I) will attend one study visit consisting of basic linear and curved IASTM stroke pattern applications and complete a questionnaire. Total study duration for clinician participants will be 90 minutes. Non-clinician subjects will attend two study visits (Phase II) or one study visit (Phase III). Visits will consist of completion of questionnaires, application of IASTM strokes by a clinician using the QSTM device, and stretching.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phase I Instrument-Assisted Soft Tissue Manipulation (IASTM) Stroke Pattern Analysis | Fifteen (n=15) experienced clinicians, each with 8 or more years experiences in instrument-assisted soft tissue manipulation (IASTM), will participate in an observational studying analyzing their application of basic stroke patterns (linear, curved) to a consistent research assistant/model. IASTM is a type of massage that uses rigid devices. A Quantifiable Soft Tissue Manipulation (QSTM) device system will be used for determining objective metrics of stroke parameters (e.g. stroke force, rate, angle) and results will be compared between participants to determine characteristic stroke profile patterns for use in training and research. | ||
| Phase II Consistency of IASTM Force Application | The reproducibility of applying a targeted STM stroke force will be determined within and between therapists, both with and without visual monitoring of the QSTM metrics and graphic display. Two novice and two experienced therapists will be trained using QSTM. A novice is defined as a clinician with <1 year and an experienced with >8 years of practice. Fifty (n=50) healthy, non-obese subjects will be enrolled that meet the inclusion/exclusion criteria. First, the clinicians will apply a self-perceived "moderate" force for 15sec (non-therapeutic dose), within subject tolerance, without using QSTM feedback. Then, the clinician will apply a targeted force of 10N with visual monitoring of QSTM feedback. This process will be repeated 5-7 days later to determine repeatability. After testing, subjects will participate in simple back and/or leg stretches and an ice pack applied. | ||
| Phase III Reliability of Dynamic Pressure Pain Threshold Assessment | The reliability of dynamic pressure pain threshold (DPPT) assessment over a specified area will be determined. Two novice and two experienced clinicians will be trained using QSTM. Subjects (n=50) will be recruited that meet the inclusion/exclusion criteria of healthy, non-obese, younger (≥18 but ≤30yo) and older individuals (≥50 but ≤75yo) (males and females). The clinicians will apply force to standardized areas of the back and thigh regions for 1 min, using the Quantifiable Soft Tissue Manipulation (QSTM) device system. The force applied will be applied up to but below the threshold of when a subject says to "stop" when they feel the "pressure" change into any sort of "irritating discomfort/pain." Secondary clinical outcomes will be assessed before and after testing since testing could have effects on the soft tissue, pain, and physical performance measures. After testing, the subject will be instructed in simple back and/or leg stretches and an ice pack applied. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Quantifiable Soft Tissue Manipulation (QSTM) | Device | Quantifiable soft tissue manipulation (QSTM) is a force sensing device system that can be used by a clinician to apply a massaging force while the system monitors objective metrics, i.e., the amount, rate, and angle of force applied. |
| Measure | Description | Time Frame |
|---|---|---|
| Phase I Stroke Pattern Characteristic Descriptions | The objectives metrics from quantifiable soft tissue manipulation device system will be analyzed for common or characteristic applications between clinicians. | Analysis results within 6 months. |
| Phase II Reliability of IASTM Force Application | The agreement in soft tissue manipulation force application, between and within clinicians, will be determined within a single session and between session (within 7 days apart). | Measured within 2 hours for same day reliability and at 7 days for between day reliability. Results reported by end of study at one year |
| Phase III Reliability of Dynamic Pressure Pain Threshold Assessment | The agreement between and within clinicians in pressure pain threshold assessment over a body area will be determined within a single session. | Measured within 2 hours on same day of testing. Results reported by end of study at one year. |
| Measure | Description | Time Frame |
|---|---|---|
| (Phase III Only) Heart Rate | Radial pulse will be palpated to determine heart rate (in beats per minute, BPM). | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Blood Pressure |
Not provided
Inclusion Criteria:
Phase I
Phase II
Phase III
Exclusion Criteria:
Phase I
Phase II
Phase III 1. The same exclusion criteria as for Phase II.
-
Not provided
Not provided
Not provided
Healthy, males and females, ages 18-75.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mary T Loghmani, PhD | Indiana University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 | United States |
Upon request.
After July 31, 2022 for one year
Other research institution PI or as requested upon review.
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
Will determine systolic and diastolic blood pressure (in mmHg) using a stethoscope and sphygmomanometer. |
| Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Range of Motion | Will measure the amount (range) of trunk movement (in degrees) using a modified protractor. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Hamstring Length Flexibility Test. | Will measure the amount (range) of passive knee extension movement available (in degrees) with the hip stabilized at 90 degrees using a modified protractor. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Trunk Forward Bend Flexibility Test. | A tape measurer/ruler will be used to determine the extensibility (e.g. limberness) of the posterior (back) trunk soft tissues during seated trunk forward bend (reaching) muscle length test (change from start to end of test measured in centimeters). | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Strength | A handheld dynamometer will be used to test the strength (Newtons of force) of the subject's back and thigh. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Static Pressure Pain Threshold | This test will determine a subject's pressure pain sensitivity in a single spot using a non-invasive device, i.e. static algometer. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Skin Surface Temperature | Changes in skin surface temperature will be determined using an infrared thermometer of the skin are where IASTM is applied on the back and thigh. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) 10-Meter Walk Test (10-MWT) | Maximal walking speed (MWS) (in meters/sec) will be determined using the 10-meter walk test as a functional performance measure. | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |
| (Phase III Only) Vertical Jump Test | The vertical jumping height (in centimeters) (only in subjects 18-30 y.o.) will be determined as a functional performance measure | Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year. |